» Articles » PMID: 28476483

Cancer Incidence and Mortality in China, 2013

Overview
Journal Cancer Lett
Specialty Oncology
Date 2017 May 7
PMID 28476483
Citations 233
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: National Central Cancer Registry of China (NCCRC) updated nationwide statistics of cancer incidence and mortality in China using population-based cancer registration data in 2013 from all available cancer registries.

Methods: In 2016, 255 registries' data were qualified and included in this analysis. We estimated numbers of new cancer cases and deaths in China in 2013 using age-specific rates and corresponding national population stratified by area, sex, age group (0, 1-4, 5-9, 10-14…85+) and cancer type. The world Segi's population was applied for age-standardized rates. All rates were expressed per 100,000 person-year.

Results: A total of 3,682,000 new cancer cases and 2,229,300 cancer deaths were estimated in China in 2013. Cancers of lung, female breast, stomach, liver, colon-rectum and esophagus were the most common cancers, accounting for about half of all cancer new cases. Lung cancer, liver cancer, stomach cancer, esophageal cancer, colorectal cancer were the five leading causes of cancer death, accounting for about 60% of all cancer deaths. The cancer patterns showed differences not only between male and female, but also among different geographic regions in China. For overall cancers, the age-standardized incidence rates were stable during the past decades in male, but significantly increased by 2.2% per year in female.

Conclusions: Cancer poses a major threat to public health and the cancer burden keep raising in China. The annual updated cancer statistics can provide scientific basis for cancer prevention and control.

Citing Articles

Current status of cytokine-induced killer cells and combination regimens in breast cancer.

Jiang Y, Qiu J, Ye N, Xu Y Front Immunol. 2025; 16:1476644.

PMID: 39981243 PMC: 11839775. DOI: 10.3389/fimmu.2025.1476644.


Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021.

Zhang C, Chen L, Xiu Y, Zhang H, Zhang Y, Ying W Front Oncol. 2025; 14:1518567.

PMID: 39902130 PMC: 11788179. DOI: 10.3389/fonc.2024.1518567.


Development of a nomogram for overall survival in patients with esophageal carcinoma: A prospective cohort study in China.

Yu S, Zheng X, Li X, Xu Q, Zhang W, Liao Z World J Gastrointest Oncol. 2025; 17(1):96686.

PMID: 39817137 PMC: 11664612. DOI: 10.4251/wjgo.v17.i1.96686.


Long-term survival and risk factors in esophageal squamous cell carcinoma: A Kaplan-Meier and cox regression study.

Ren Z, Kang M, Zhu L, Li P World J Gastrointest Surg. 2024; 16(12):3772-3779.

PMID: 39734461 PMC: 11650227. DOI: 10.4240/wjgs.v16.i12.3772.


A novel electrochemical immunosensor for the ultrasensitive detection of vascular endothelial growth factor based on MB@Cu-MOFs/MWCNTs composite.

Liu J, Wu S, Zhang L, Zhang M, Wu H, Shi M Mikrochim Acta. 2024; 192(1):37.

PMID: 39730872 DOI: 10.1007/s00604-024-06884-2.